GO:0070482 response to oxygen levels: Cellular Adaptation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070482 response to oxygen levels describes any process by which a cell or organism changes its state or activity in response to the presence, absence, or concentration of oxygen.
• The hypoxia-inducible factor (HIF) pathway is the best-characterized oxygen-sensing mechanism, controlling transcriptional adaptation to low oxygen.
• Oxygen levels influence cell cycle progression, metabolism, immune function, and oxidative stress responses.
• Dysregulated oxygen responses contribute to cancer progression, diabetes complications, and ischemic diseases.
• Both hypoxia and hyperoxia can trigger adaptive responses, as illustrated by the hyperoxic-hypoxic paradox.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of oxygen-response genes.
Description
Oxygen is essential for aerobic life, and cells must constantly sense and respond to changes in oxygen availability. The Gene Ontology term GO:0070482, response to oxygen levels, captures any process that results in a change in state or activity of a cell or an organism as a result of a stimulus reflecting the presence, absence, or concentration of oxygen. This includes transcriptional, metabolic, and signaling adaptations that allow cells to survive and function under varying oxygen tensions. Understanding this process is fundamental to physiology and disease, as oxygen dysregulation is implicated in cancer, diabetes, and ischemic injury. The HIF (hypoxia-inducible factor) pathway is the central mediator of oxygen sensing, orchestrating gene expression changes that affect metabolism, angiogenesis, and immune responses. Beyond HIF, other pathways such as NRF2-mediated oxidative stress responses and cell cycle checkpoints also respond to oxygen levels. The interplay between these pathways determines cell fate under hypoxia or hyperoxia. Research into response to oxygen levels spans molecular biology, cancer biology, and regenerative medicine. Experimental models using CRISPR gene editing allow precise manipulation of oxygen-sensing genes to uncover causal mechanisms. This article provides a comprehensive overview of GO:0070482, its mechanisms, key genes, disease relevance, and research methodologies.
response to oxygen levels At A Glance
| GO ID | GO:0070482 |
|---|---|
| GO term | response to oxygen levels |
| Ontology | biological_process |
| Synonym | none |
| Major function | Cellular and organismal adaptation to changes in oxygen availability, including transcriptional, metabolic, and signaling responses. |
| Key mediators | HIF transcription factors, prolyl hydroxylases (PHDs), von Hippel-Lindau (VHL) protein, NRF2, and cell cycle regulators. |
| Associated diseases | Cancer, diabetes, ischemia, and inflammatory conditions. |
| Research methods | CRISPR knockout/knock-in, RNA-seq, proteomics, imaging, and hypoxia chambers. |
What Is GO:0070482?
GO:0070482 response to oxygen levels is defined as any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of oxygen. This biological process encompasses both short-term and long-term adaptations to hypoxia (low oxygen) and hyperoxia (high oxygen), integrating signaling cascades, transcriptional programs, and metabolic rewiring.
Why Is response to oxygen levels Important in Cell Biology?
Response to oxygen levels is fundamental to life because oxygen availability directly impacts cellular energetics, redox balance, and survival. The HIF pathway, a key mediator of this response, regulates hundreds of genes involved in angiogenesis, metabolism, and immune evasion. Dysregulation of oxygen sensing contributes to cancer progression, where hypoxic tumors are more aggressive and resistant to therapy. In diabetes, hypoxia and HIF signaling exacerbate complications such as retinopathy and nephropathy. Understanding GO:0070482 is therefore critical for developing therapeutic strategies targeting oxygen-sensing pathways.
• Hypoxia drives tumor progression and metastasis through HIF-mediated gene expression.
• HIF signaling influences immune cell function and inflammation.
• Oxygen levels regulate cell cycle progression and proliferation.
• Oxidative stress responses intersect with oxygen sensing via NRF2.
• Diabetes complications involve hypoxia and HIF dysregulation.
• Hyperoxic-hypoxic paradox shows that both high and low oxygen trigger adaptive responses.
• Oxygen sensing is critical for normal development and tissue homeostasis.
• Therapeutic targeting of oxygen-sensing pathways is explored in cancer and ischemia.
• Extracorporeal oxygenation and ozone therapy modulate oxygen-related responses.
• CRISPR screens identify novel regulators of oxygen response.
What Happens During response to oxygen levels?
Oxygen Sensing and HIF Stabilization
In simple terms: When oxygen is low, cells stabilize a protein called HIF that turns on survival genes.
Under normoxia, prolyl hydroxylases (PHDs) hydroxylate HIF-alpha subunits, marking them for VHL-mediated degradation. When oxygen levels drop, PHD activity is inhibited, allowing HIF-alpha to accumulate and translocate to the nucleus, where it dimerizes with HIF-beta and activates transcription of target genes.
Transcriptional Reprogramming
In simple terms: HIF switches on many genes that help cells cope with low oxygen.
HIF targets include genes involved in angiogenesis (VEGFA), glycolysis (LDHA, GLUT1), and survival (BNIP3). This transcriptional program enhances oxygen delivery and metabolic adaptation.
Metabolic Adaptation
In simple terms: Cells change how they make energy when oxygen is scarce.
Hypoxia shifts metabolism from oxidative phosphorylation to glycolysis, reducing oxygen consumption. HIF regulates this switch by upregulating glycolytic enzymes and suppressing mitochondrial function.
Cell Cycle Regulation
In simple terms: Oxygen levels can slow down or stop cell division.
Hypoxia induces cell cycle arrest at various phases through mechanisms involving p53, p21, and cyclin-dependent kinase inhibitors. This allows cells to avoid replication stress under low oxygen.
Oxidative Stress Response
In simple terms: Cells also manage damaging molecules when oxygen changes.
NRF2, a master regulator of antioxidant responses, interacts with HIF signaling. Hypoxia can increase reactive oxygen species (ROS), activating NRF2 to restore redox balance.
Hyperoxic Responses
In simple terms: Too much oxygen can also trigger protective responses.
Hyperoxia can paradoxically induce HIF and other adaptive pathways, a phenomenon known as the hyperoxic-hypoxic paradox, which has implications for oxygen therapy.
Key Genes Involved in GO:0070482 response to oxygen levels
The following genes and proteins are central to the response to oxygen levels, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HIF1A | Oxygen-sensitive subunit of HIF-1; regulates transcription of hypoxia-inducible genes | Knockout models show impaired hypoxia adaptation; target for cancer therapy |
| EPAS1 (HIF2A) | Oxygen-sensitive subunit of HIF-2; regulates erythropoiesis and angiogenesis | Point mutations linked to polycythemia; knockout studies in development |
| VHL | E3 ubiquitin ligase that targets HIF-alpha for degradation under normoxia | Loss causes von Hippel-Lindau disease; knockout models for cancer |
| EGLN1 (PHD2) | Prolyl hydroxylase that senses oxygen and hydroxylates HIF-alpha | Knockout leads to HIF stabilization; point mutations affect oxygen sensing |
| ARNT (HIF1B) | Dimerization partner for HIF-alpha; required for HIF transcriptional activity | Knockout is embryonic lethal; used to study HIF-independent functions |
| VEGFA | HIF target gene; promotes angiogenesis | Overexpression models for vascular research |
| LDHA | HIF target; converts pyruvate to lactate under hypoxia | Knockout reduces glycolytic flux; cancer metabolism studies |
| SLC2A1 (GLUT1) | HIF target; glucose transporter | Overexpression increases glucose uptake; diabetes research |
| BNIP3 | HIF target; regulates autophagy and apoptosis | Knockout affects cell survival under hypoxia |
| NFE2L2 (NRF2) | Antioxidant response regulator; crosstalk with HIF | Knockout increases oxidative stress; cancer and diabetes models |
| CDKN1A (p21) | Cell cycle inhibitor induced by hypoxia | Knockout deregulates cell cycle under low oxygen |
| TP53 | Tumor suppressor; mediates hypoxia-induced apoptosis | Point mutations common in cancer; affects hypoxia response |
| MTOR | Kinase that integrates oxygen and nutrient signals | Knockout disrupts metabolism; drug target |
| EPO | HIF target; stimulates red blood cell production | Overexpression models for anemia |
| TGFB1 | Cytokine involved in hypoxia-induced fibrosis | Knockout reduces fibrosis in diabetes models |
| SOD2 | Mitochondrial antioxidant enzyme; regulated by oxygen levels | Overexpression protects against oxidative stress |
| CASP3 | Executioner caspase in hypoxia-induced apoptosis | Knockout reduces cell death |
| KDM6A | Histone demethylase that interacts with HIF | Knockout alters hypoxia gene expression |
How Is response to oxygen levels Regulated?
The response to oxygen levels is tightly regulated at multiple levels. The primary mechanism involves oxygen-dependent hydroxylation of HIF-alpha by PHDs, which requires oxygen, iron, and 2-oxoglutarate as cofactors. Under normoxia, hydroxylated HIF-alpha is recognized by VHL and targeted for proteasomal degradation. Under hypoxia, PHD activity is inhibited, allowing HIF-alpha accumulation. Additionally, mTOR signaling integrates oxygen availability with nutrient status to regulate cell growth. NRF2 provides feedback regulation of oxidative stress during hypoxia. Cell cycle checkpoints also modulate the response to oxygen levels through p53 and p21.
response to oxygen levels and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HIF1A | Cancer progression, ischemia | Knockout and overexpression in cancer cell lines |
| VHL | Von Hippel-Lindau disease, renal cell carcinoma | Knockout in renal cells; point mutations |
| EPAS1 | Polycythemia, neuroblastoma | Point mutation knock-in in hematopoietic cells |
| EGLN1 | Hypoxia-related disorders | Knockout and point mutation in fibroblasts |
| NFE2L2 | Cancer, diabetes complications | Knockout and overexpression in oxidative stress models |
Cancer
Hypoxia is a hallmark of solid tumors, driving aggressive phenotypes and resistance to therapy. HIF activation promotes angiogenesis, metabolic reprogramming, and immune evasion, contributing to poor prognosis. Targeting HIF or its downstream effectors is a major therapeutic strategy.
Diabetes and Its Complications
Hypoxia and HIF dysregulation are implicated in diabetic retinopathy, nephropathy, and neuropathy. Hyperglycemia can exacerbate hypoxia-induced damage, and HIF activation may be protective or detrimental depending on context.
Ischemia and Cardiovascular Disease
Ischemic conditions such as myocardial infarction and stroke involve acute oxygen deprivation. The HIF pathway mediates adaptive responses that can limit tissue damage, making it a target for cardioprotection.
Oxidative Stress and Inflammation
The interplay between HIF and NRF2 influences inflammatory responses and redox balance. Dysregulation contributes to chronic inflammatory diseases and cancer.
From response to oxygen levels-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does HIF1A knockout impair hypoxia-induced glycolysis? | HIF1A knockout cell line (e.g., HepG2) |
| What is the effect of a VHL point mutation on HIF stability? | VHL point mutation knock-in via CRISPR |
| Can overexpression of NRF2 protect against hypoxia-induced ROS? | NRF2 overexpression cell model |
| How does EPAS1 mutation affect erythropoiesis? | EPAS1 point mutation knock-in in iPSCs |
| Is BNIP3 required for hypoxia-induced autophagy? | BNIP3 knockout HeLa cells |
| What is the role of CDKN1A in hypoxia-induced cell cycle arrest? | CDKN1A knockout HCT116 cells |
How to Study the response to oxygen levels Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identifying HIF target genes under hypoxia |
| Proteomics | Protein abundance and modifications | Detecting HIF stabilization and post-translational changes |
| Metabolomics | Metabolite levels and fluxes | Assessing glycolytic shift under hypoxia |
| Hypoxia chamber | Controlled oxygen tension | Simulating physiological and pathological oxygen levels |
| HRE-luciferase reporter | HIF transcriptional activity | High-throughput screening for HIF modulators |
| CRISPR knockout screen | Gene function loss | Discovering novel oxygen-response regulators |
| ChIP-seq | HIF DNA binding sites | Mapping HIF target promoters |
| Immunoblotting | Protein expression and degradation | Measuring HIF-alpha stability |
Transcriptomic Analysis
RNA-seq is widely used to profile gene expression changes in response to varying oxygen levels. It identifies HIF target genes and other oxygen-regulated transcripts.
Proteomic and Metabolomic Profiling
Mass spectrometry-based proteomics and metabolomics reveal changes in protein abundance and metabolic fluxes under hypoxia, providing insights into adaptive mechanisms.
Imaging and Reporter Assays
Hypoxia reporters (e.g., HRE-luciferase) and fluorescence imaging allow real-time monitoring of oxygen responses in live cells and tissues.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens identify novel regulators of the response to oxygen levels, uncovering potential therapeutic targets.
How CRISPR Can Be Used to Study GO:0070482 response to oxygen levels
Knockout
CRISPR knockout of oxygen-sensing genes such as HIF1A, VHL, or EGLN1 allows researchers to study loss-of-function phenotypes. For example, HIF1A knockout cells fail to induce glycolytic genes under hypoxia.
Point Mutation
Introducing specific point mutations (e.g., in VHL or EPAS1) via CRISPR base editing or HDR mimics disease-associated variants, enabling functional studies of oxygen sensing.
Knock-in
Knock-in of reporter tags (e.g., GFP) or disease alleles into endogenous loci provides physiological expression control. Tagged HIF1A knock-in allows live-cell imaging of protein dynamics.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of genes like NRF2 or VEGFA can model gain-of-function states and test therapeutic hypotheses.
How EDITGENE Supports response to oxygen levels Research
Researchers studying response to oxygen levels-related genes often need to determine whether a candidate gene is causally involved in hypoxia adaptation, metabolic reprogramming, or disease progression. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation.
Contact EDITGENE today to design your custom CRISPR model for response to oxygen levels research.
Frequently Asked Questions About response to oxygen levels
What is GO:0070482 response to oxygen levels?
GO:0070482 is a Gene Ontology biological process term defined as any process that results in a change in state or activity of a cell or an organism as a result of a stimulus reflecting the presence, absence, or concentration of oxygen.
What genes are involved in response to oxygen levels?
Key genes include HIF1A, EPAS1, VHL, EGLN1, ARNT, VEGFA, LDHA, SLC2A1, BNIP3, NFE2L2, CDKN1A, and TP53, among others.
How does hypoxia affect cells?
Hypoxia stabilizes HIF transcription factors, which activate genes that promote angiogenesis, glycolysis, and survival, while also inducing cell cycle arrest and oxidative stress responses.
What is the role of HIF in cancer?
HIF promotes tumor progression by inducing angiogenesis, metabolic reprogramming, and immune evasion, making it a therapeutic target.
How is response to oxygen levels studied in the lab?
Common methods include RNA-seq, proteomics, metabolomics, hypoxia chambers, reporter assays, and CRISPR screens.
What is the hyperoxic-hypoxic paradox?
It is the phenomenon where hyperoxia can induce adaptive responses similar to hypoxia, involving HIF and other pathways.
Can CRISPR be used to study oxygen response genes?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in oxygen response.
What diseases are linked to oxygen response dysregulation?
Cancer, diabetes complications, ischemia, and inflammatory diseases are associated with altered oxygen sensing.
What is the role of NRF2 in oxygen response?
NRF2 regulates antioxidant responses and crosstalks with HIF signaling to manage oxidative stress during hypoxia.
How does oxygen levels affect the cell cycle?
Hypoxia can induce cell cycle arrest through p53 and p21, allowing cells to adapt to low oxygen.
Conclusion
GO:0070482 response to oxygen levels is a fundamental biological process with broad implications for physiology and disease. The HIF pathway and its regulators are central to oxygen sensing, but other pathways such as NRF2 and cell cycle checkpoints also contribute. Understanding these mechanisms is essential for developing therapies for cancer, diabetes, and ischemic diseases. CRISPR-based models provide powerful tools to dissect gene function and identify new therapeutic targets.
References
- 1. Lee P et al.. 2020. Cellular adaptation to hypoxia through hypoxia inducible factors and beyond.. Nat Rev Mol Cell Biol 21(5):268-283 PMID: 32144406
- 2. Taylor CT et al.. 2022. The effect of HIF on metabolism and immunity.. Nat Rev Nephrol 18(9):573-587 PMID: 35726016
- 3. Ortmann B et al.. 2014. Cell cycle progression in response to oxygen levels.. Cell Mol Life Sci 71(18):3569-82 PMID: 24858415
- 4. Vaupel P et al.. 2024. Master Role of Hypoxia in Cancer Progression: Major Insights During ISOTT's Half-Century.. Adv Exp Med Biol 1463:15-20 PMID: 39400793
- 5. Catrina SB et al.. 2021. Hypoxia and hypoxia-inducible factors in diabetes and its complications.. Diabetologia 64(4):709-716 PMID: 33496820
- 6. Bae T et al.. 2024. Hypoxia, oxidative stress, and the interplay of HIFs and NRF2 signaling in cancer.. Exp Mol Med 56(3):501-514 PMID: 38424190
- 7. Hadanny A et al.. 2020. The Hyperoxic-Hypoxic Paradox.. Biomolecules 10(6) PMID: 32630465
- 8. Di Paolo N et al.. 2005. Extracorporeal blood oxygenation and ozonation: clinical and biological implications of ozone therapy.. Redox Rep 10(3):121-30 PMID: 16156950
